title: [Selective progesterone receptor modulatores for uterine fibroid treatment--the statement of the Polish Gynecological Society experts].
authors.forename: Romuald
authors.initials: R
authors.lastname: Debski
authors.forename: Jan
authors.initials: J
authors.lastname: Kotarski
authors.forename: Tomasz
authors.initials: T
authors.lastname: Paszkowski
authors.forename: Ryszard
authors.initials: R
authors.lastname: Poreba
authors.forename: Violetta
authors.initials: V
authors.lastname: Skrzypulec-Plinta
authors.forename: Marek
authors.initials: M
authors.lastname: Spaczyński
authors.forename: Justyna
authors.initials: J
authors.lastname: Szumilo
mesh_terms: D003226:Congresses as Topic; D005260:Female; D006176:Gynecology / Q000592:standards; D006801:Humans; D007318:Inservice Training / Q000592:standards; D007889:Leiomyoma / Q000188:drug therapy*; D009313:National Health Programs / Q000592:standards; D009774:Obstetrics / Q000592:standards; D011044:Poland; D011785:Quality Assurance, Health Care / Q000592:standards; D011980:Receptors, Progesterone / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D012955:Societies, Medical / Q000592:standards; D014594:Uterine Neoplasms / Q000188:drug therapy*
chemical_list: D011980:Receptors, Progesterone